StudyIn 2016, Arthrex published a study comparing three BMC systems including the Arthrex Angel® BMC, Harvest SmartPReP BMAC, and Arteriocyte Magellan MAR0Max. The purpose of this study was to compare the cellular content utilizing Bone Marrow Aspirate (BMA).
Method:BMA was harvested from five donors which resulted in about 100 mL of BMA. The BMA was then divided between the three systems and went through each company’s standard procedure. After processing, the BMC was tested for several cell concentrations: red blood cells, white blood cells, neutrophils, platelets, total nucleated cells and hematopoietic cells.
Results:The Arthrex Angel System produced significantly higher total nucleated cell and hematopoietic cell concentrations compared to the Harvest and Magellan systems. This shows that the Angel System provides the best opportunity to relieve pain as hematopoietic cells have the potential to repair damaged tissue.
At Bio-Alliance Medical Group, we promise to create a treatment program specific to you. With our advanced technology, we can manually input the values that we believe will provide the best results for you and your injury. Unlock your healing potential today!